Novo Nordisk has said it is discontinuing selling its popular, best-selling insulin brand in India and will instead promote ...

Danish pharmaceutical giant Novo Nordisk has announced plans to phase out Human Mixtard, India's top-selling insulin brand.

The FDA and Novo Nordisk are warning of counterfeit Ozempic® (semaglutide) which could pose a safety risk. The FDA and ...

(CNN) - The Food and Drug Administration is warning of fake Ozempic that could pose a safety risk. The FDA and Ozempic ...

Novo Nordisk will discontinue Human Mixtard, a top-selling insulin in India. This decision aligns with the company's global ...

In this edition of Daily Dose, Dr. Lacy Anderson answers a viewer's question about what discounts are available for weight ...

In December, the agency said it seized thousands of units of fake Ozempic and warned that some may still be available for purchase.

LUBBOCK, Texas (KCBD) - The Federal Drug Administration is warning of fake Ozempic, saying it could pose a safety risk. The ...

The FDA and Ozempic manufacturer Novo Nordisk have found counterfeit vials of the weight-loss drug being sold to consumers. The labels on the counterfeit products have a real lot number “PAR0362 ...

MONTGOMERY, Ala. (WSFA) - The FDA is warning people about fake Ozempic after counterfeit vials of the weight loss drug were sold to consumers. In December, the agency said it seized thousands of ...